Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis.
about
Advantages and Challenges of Dried Blood Spot Analysis by Mass Spectrometry Across the Total Testing ProcessGeneva cocktail for cytochrome p450 and P-glycoprotein activity assessment using dried blood spots.Direct analysis of dried blood spots coupled with mass spectrometry: concepts and biomedical applications.State-of-the-art dried blood spot analysis: an overview of recent advances and future trends.Dried blood spots: concepts, present status, and future perspectives in bioanalysis.Therapeutic drug monitoring by dried blood spot: progress to date and future directions.The use of mass spectrometry to analyze dried blood spots.Challenges and opportunities in mass spectrometric analysis of proteins from dried blood spots.Procedures and practices for the validation of bioanalytical methods using dried blood spots: a review.Current advances in biosampling for therapeutic drug monitoring of psychiatric CNS drugs.Sensitive determination of prohibited drugs in dried blood spots (DBS) for doping controls by means of a benchtop quadrupole/Orbitrap mass spectrometer.Body fluid and tissue analysis using filter paper sampling support prior to LC-MS/MS: application to fatal overdose with colchicine.Liquid extraction surface analysis field asymmetric waveform ion mobility spectrometry mass spectrometry for the analysis of dried blood spots.Simultaneous LC-MS/MS quantification of P-glycoprotein and cytochrome P450 probe substrates and their metabolites in DBS and plasma.Use of conventional bioanalytical devices to automate DBS extractions in liquid-handling dispensing tips.Rapid LC-MS/MS quantification of the major benzodiazepines and their metabolites on dried blood spots using a simple and cost-effective sample pretreatment.Simultaneous Quantification of Antidepressants and Metabolites in Urine and Plasma Samples by GC–MS for Therapeutic Drug Monitoring
P2860
Q29109543-E66CCB52-693A-48F9-993F-ECF65D510706Q34116690-42CB959D-3FFA-4EE6-B9BC-1635369B2241Q37894587-DA2D5368-0FF7-487A-B273-A26039172AC2Q38130332-A8CE24B0-2A76-454E-AB2D-B7F187D75374Q38201371-08067CFC-ACB5-4FCE-A56D-C7415C8EDCBEQ38247481-8A9DD362-0D31-469C-88ED-0306C10CF875Q38253959-8B51EEC2-21B0-444A-8A77-392ABA4E3F6CQ38259485-ECE266C7-E539-43EC-BD4D-4426F12851DAQ38266632-29282BA3-DE5A-4FC8-94A5-8829599EF5A1Q38571074-1DC99DA7-BA87-4494-A9C5-59CF46B2FF60Q45854049-B87E314E-C648-439B-88DA-608C8CF2FD53Q46306823-04FAD6A4-4D26-441F-AD9A-F712026AC140Q46697012-2856BDDB-CC87-4EEE-89D5-6933880035AEQ47925032-6965ECC5-CBAD-4D27-A0E2-6B7456E3F2ECQ48221188-C405D760-C08C-4B35-B371-554F5EB080CDQ53128171-E01E7852-6DFD-4CCF-B955-DF189B6A881DQ57888862-D79D2C8C-4C01-4002-A2F5-1F45ED1F7FC8
P2860
Use of the dried blood spot sampling process coupled with fast gas chromatography and negative-ion chemical ionization tandem mass spectrometry: application to fluoxetine, norfluoxetine, reboxetine, and paroxetine analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@en
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@nl
type
label
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@en
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@nl
prefLabel
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@en
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@nl
P2093
P1476
Use of the dried blood spot sa ...... tine, and paroxetine analysis.
@en
P2093
Christian Staub
Estelle Lauer
Patrice Mangin
P2888
P304
P356
10.1007/S00216-009-3412-6
P407
P577
2010-01-10T00:00:00Z